Healthpeak Properties (DOC) to Release Earnings on Tuesday

Healthpeak Properties (NYSE:DOC) is anticipated to issue its Q1 2026 results after the market closes on Tuesday, May 5th. Analysts expect the company to announce earnings of $0.0528 per share and revenue of $694.5880 million for the quarter. Individuals can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 10:00 AM ET.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The firm had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. During the same quarter last year, the business posted $0.46 EPS. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, analysts expect Healthpeak Properties to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Healthpeak Properties Trading Up 1.7%

Shares of Healthpeak Properties stock opened at $16.44 on Monday. The firm has a market cap of $11.43 billion, a price-to-earnings ratio of 164.42, a price-to-earnings-growth ratio of 2.27 and a beta of 1.00. Healthpeak Properties has a 52-week low of $15.70 and a 52-week high of $19.68. The company’s 50-day simple moving average is $16.94 and its 200-day simple moving average is $17.15. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be issued a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) dividend on an annualized basis and a yield of 7.4%. Healthpeak Properties’s payout ratio is currently 1,220.00%.

Institutional Investors Weigh In On Healthpeak Properties

Institutional investors and hedge funds have recently bought and sold shares of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after acquiring an additional 7,007,777 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after purchasing an additional 4,776,056 shares during the last quarter. Millennium Management LLC grew its holdings in shares of Healthpeak Properties by 235.3% during the fourth quarter. Millennium Management LLC now owns 3,512,223 shares of the real estate investment trust’s stock worth $56,477,000 after buying an additional 2,464,612 shares in the last quarter. Bank of America Corp DE grew its holdings in shares of Healthpeak Properties by 28.5% during the third quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock worth $190,292,000 after buying an additional 2,206,222 shares in the last quarter. Finally, Invesco Ltd. raised its position in shares of Healthpeak Properties by 9.9% in the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock valued at $294,244,000 after buying an additional 1,648,012 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Evercore dropped their target price on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Wells Fargo & Company reissued a “positive” rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. The Goldman Sachs Group started coverage on Healthpeak Properties in a report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price target on the stock. Morgan Stanley dropped their price objective on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 28th. Finally, Robert W. Baird reduced their price objective on Healthpeak Properties from $20.00 to $19.00 and set an “outperform” rating for the company in a report on Monday, April 6th. Five analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, Healthpeak Properties currently has an average rating of “Hold” and a consensus target price of $18.04.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.